In regard to our recent Review , we would suggest that these are only necessary on a routine basis when the boundaries between positive and negative populations are not obvious from other means. When there is clear separation between the populations or when a true negative population exists within the sample or experiment, a gating control is not needed. It should also be noted that FMO controls do not account for nonspecific antibody binding, so they are imperfect gating controls when significant nonspecific antibody staining is present.
We agree with Petriz and colleagues regarding the usefulness of proficiency testing studies and the high degree of variability that can result from differential gating. They describe high inter-laboratory variability in terms of counting discrete subsets such as CD45 + 
